Russia /
Russia will bring to the market its Nasal Covid-19 Vaccine Sputnik in the first quarter of 2022, as reported today by the Gamaleya Center, producer of this drug.
“The Sputnik nasal vaccine will be supplied to the market in the first quarter of 2022,” the center reported on its official Twitter account.
According to him Centro Gamelaya, the nasal vaccine, the development of which Russia reported in the middle of the year, “will be especially effective against the highly contagious omicron variant, as it will not only protect against infection, but also will prevent transmission“.
The President of Russia, Vladimir Putin, who participated last November in the rehearsals of the nasal preparation, highlighted yesterday that the two-dose Russian covid vaccine Sputnik V it is highly effective against the omicron variant and stated that it “guarantees about 90% protection”.
Until now, Sputnik V has been approved for use in more than 70 countries and 21 other states have also approved Sputnik Light.
The creators of the Russian vaccine argue that at the moment there is no need to develop a new drug for the omicron variant.
MJVR
–
– .
